Illumina Inc. v. BGI Genomics Co., Ltd.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 ILLUMINA INC., et al., Case No. 20-cv-01465-WHO (TSH)
Plaintiffs,
DISCOVERY ORDER
v. Re: Dkt. No. 200 BGI GENOMICS CO., LTD., et al., Defendants.
12 We are here on a joint discovery letter brief concerning some of Defendants’ interrogatory (“rog”) responses and responses to requests for production (“RFPs”). ECF No. 200. The Court held a hearing on November 30, 2020, and now issues this order. A. Design Around Our first dispute concerns Illumina’s attempt to take discovery into any efforts Defendants may have made to design around Illumina’s patents. Illumina’s rog 11 asks Defendants to “[s]et forth in detail each change and/or modification that You have made, or plan to make, to the design, operation, or use of the BGI Accused Products as a result of or in response to Your becoming aware of the Illumina Asserted Patents or the filing of this lawsuit or any other legal action brought by Illumina against any of the Defendants involving…